During the early-phase of ICH (day 1–3), HO-1 increases brain edema, white matter and neuronal damage, and elevates inflammation and iron deposition, but in the late-phase (day 28), HO-1 increases hematoma absorption and recovery of neurologic functions [116]. The gene discussed is HMOX1; the disease is hematoma.